These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 29094256

  • 1. Efficacy of dexamethasone suppression test during the diagnosis of primary pigmented nodular adrenocortical disease in Chinese adrenocorticotropic hormone-independent Cushing syndrome.
    Chen S, Li R, Lu L, Duan L, Zhang X, Tong A, Pan H, Zhu H, Lu Z.
    Endocrine; 2018 Jan; 59(1):183-190. PubMed ID: 29094256
    [Abstract] [Full Text] [Related]

  • 2. [Comparison of efficacy between the serum cortisol and 24 hour urine free cortisol in combined dexamethasone suppression test in the diagnosis of Cushing syndrome].
    Lu L, Chen JH, Zhu HJ, Song AL, Li M, Chen S, Pan H, Gong FY, Wang RZ, Xing B, Yao Y, Feng M, Lu ZL.
    Zhonghua Yi Xue Za Zhi; 2016 Jul 19; 96(27):2150-4. PubMed ID: 27464539
    [Abstract] [Full Text] [Related]

  • 3. An unusual presentation of Carney complex with diffuse primary pigmented nodular adrenocortical disease on one adrenal gland and a nonpigmented adrenocortical adenoma and focal primary pigmented nodular adrenocortical disease on the other.
    Tung SC, Hwang DY, Yang JW, Chen WJ, Lee CT.
    Endocr J; 2012 Jul 19; 59(9):823-30. PubMed ID: 22785148
    [Abstract] [Full Text] [Related]

  • 4. The role of unilateral adrenalectomy in corticotropin-independent bilateral adrenocortical hyperplasias.
    Xu Y, Rui W, Qi Y, Zhang C, Zhao J, Wang X, Wu Y, Zhu Q, Shen Z, Ning G, Zhu Y.
    World J Surg; 2013 Jul 19; 37(7):1626-32. PubMed ID: 23592061
    [Abstract] [Full Text] [Related]

  • 5. An Optimized Pathway for the Differential Diagnosis of ACTH-Dependent Cushing's Syndrome Based on Low-Dose Dexamethasone Suppression Test.
    Chen K, Chen S, Lu L, Zhu H, Zhang X, Tong A, Pan H, Wang R, Lu Z.
    Front Endocrinol (Lausanne); 2021 Jul 19; 12():720823. PubMed ID: 34539574
    [Abstract] [Full Text] [Related]

  • 6. The discriminatory value of the low-dose dexamethasone suppression test in the investigation of paediatric Cushing's syndrome.
    Dias R, Storr HL, Perry LA, Isidori AM, Grossman AB, Savage MO.
    Horm Res; 2006 Jul 19; 65(3):159-62. PubMed ID: 16514243
    [Abstract] [Full Text] [Related]

  • 7. The low-dose dexamethasone suppression test in patients with adrenal incidentalomas: comparisons with clinically euadrenal subjects and patients with Cushing's syndrome.
    Tsagarakis S, Kokkoris P, Roboti C, Malagari C, Kaskarelis J, Vlassopoulou V, Alevizaki C, Thalassinos N.
    Clin Endocrinol (Oxf); 1998 May 19; 48(5):627-33. PubMed ID: 9666875
    [Abstract] [Full Text] [Related]

  • 8. Elevated post-dexamethasone suppression cortisol concentrations correlate with hormonal alterations of the hypothalamo-pituitary adrenal axis in patients with adrenal incidentalomas.
    Tsagarakis S, Roboti C, Kokkoris P, Vasiliou V, Alevizaki C, Thalassinos N.
    Clin Endocrinol (Oxf); 1998 Aug 19; 49(2):165-71. PubMed ID: 9828902
    [Abstract] [Full Text] [Related]

  • 9. Paradoxical response to dexamethasone in the diagnosis of primary pigmented nodular adrenocortical disease.
    Stratakis CA, Sarlis N, Kirschner LS, Carney JA, Doppman JL, Nieman LK, Chrousos GP, Papanicolaou DA.
    Ann Intern Med; 1999 Oct 19; 131(8):585-91. PubMed ID: 10523219
    [Abstract] [Full Text] [Related]

  • 10. UTILITY OF A SINGLE LATE-NIGHT PLASMA CORTISOL AND ACTH FOR THE DIAGNOSIS OF CUSHING SYNDROME.
    Jarial KDS, Bhansali A, Mukherjee KK, Pal R, Sharma A, Vashishtha RK, Sukumar SP, Sachdeva N, Walia R.
    Endocr Pract; 2018 Feb 19; 24(2):156-162. PubMed ID: 29144801
    [Abstract] [Full Text] [Related]

  • 11. Primary pigmented nodular adrenocortical disease: paradoxical responses of cortisol secretion to dexamethasone occur in vitro and are associated with increased expression of the glucocorticoid receptor.
    Bourdeau I, Lacroix A, Schürch W, Caron P, Antakly T, Stratakis CA.
    J Clin Endocrinol Metab; 2003 Aug 19; 88(8):3931-7. PubMed ID: 12915689
    [Abstract] [Full Text] [Related]

  • 12. A very high dose dexamethasone suppression test for differential diagnosis of Cushing's syndrome.
    al-Saadi N, Diederich S, Oelkers W.
    Clin Endocrinol (Oxf); 1998 Jan 19; 48(1):45-51. PubMed ID: 9509067
    [Abstract] [Full Text] [Related]

  • 13. [A girl with Cushing's syndrome due to primary pigmented nodular adrenocortical disease].
    Bocca G, van Mil EG, Voorhoeve PG, Wijnaendts LC, Delemarre-van de Waal HA.
    Ned Tijdschr Geneeskd; 2006 Oct 28; 150(43):2390-3. PubMed ID: 17100132
    [Abstract] [Full Text] [Related]

  • 14. Low DHEAS: A Sensitive and Specific Test for the Detection of Subclinical Hypercortisolism in Adrenal Incidentalomas.
    Dennedy MC, Annamalai AK, Prankerd-Smith O, Freeman N, Vengopal K, Graggaber J, Koulouri O, Powlson AS, Shaw A, Halsall DJ, Gurnell M.
    J Clin Endocrinol Metab; 2017 Mar 01; 102(3):786-792. PubMed ID: 27797672
    [Abstract] [Full Text] [Related]

  • 15. Black adrenal adenoma: distinction from PPNAD.
    Kamalanathan S, Mahesh DM, Muruganandham K, Basu D.
    BMJ Case Rep; 2012 Jul 03; 2012():. PubMed ID: 22761223
    [Abstract] [Full Text] [Related]

  • 16. Diurnal Plasma Cortisol Measurements Utility in Differentiating Various Etiologies of Endogenous Cushing Syndrome.
    Tirosh A, Lodish MB, Papadakis GZ, Lyssikatos C, Belyavskaya E, Stratakis CA.
    Horm Metab Res; 2016 Sep 03; 48(10):677-681. PubMed ID: 27643448
    [Abstract] [Full Text] [Related]

  • 17. Predicting postoperative hypocortisolism in patients with non-aldosterone-producing adrenocortical adenoma: a retrospective single-centre study.
    Bonaventura I, Tomaselli A, Angelini F, Ferrari D, De Alcubierre D, Hasenmajer V, Sbardella E, Cozzolino A, Paganini AM, Isidori AM, Minnetti M, Pofi R.
    J Endocrinol Invest; 2024 Jul 03; 47(7):1751-1762. PubMed ID: 38386266
    [Abstract] [Full Text] [Related]

  • 18. Cyclical Cushing syndrome presenting in infancy: an early form of primary pigmented nodular adrenocortical disease, or a new entity?
    Gunther DF, Bourdeau I, Matyakhina L, Cassarino D, Kleiner DE, Griffin K, Courkoutsakis N, Abu-Asab M, Tsokos M, Keil M, Carney JA, Stratakis CA.
    J Clin Endocrinol Metab; 2004 Jul 03; 89(7):3173-82. PubMed ID: 15240590
    [Abstract] [Full Text] [Related]

  • 19. Regulation of steroidogenesis in a primary pigmented nodular adrenocortical disease-associated adenoma leading to virilization and subclinical Cushing's syndrome.
    Hofland J, de Herder WW, Derks L, Hofland LJ, van Koetsveld PM, de Krijger RR, van Nederveen FH, Horvath A, Stratakis CA, de Jong FH, Feelders RA.
    Eur J Endocrinol; 2013 Jan 03; 168(1):67-74. PubMed ID: 23065993
    [Abstract] [Full Text] [Related]

  • 20. The clinical conundrum of corticotropin-independent autonomous cortisol secretion in patients with bilateral adrenal masses.
    Young WF, du Plessis H, Thompson GB, Grant CS, Farley DR, Richards ML, Erickson D, Vella A, Stanson AW, Carney JA, Abboud CF, Carpenter PC.
    World J Surg; 2008 May 03; 32(5):856-62. PubMed ID: 18074172
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.